EAGLE PHARMACEUTICALS

Serial Number 86296582
Registration 4876691
702

Registration Progress

Application Filed
May 30, 2014
Under Examination
Approved for Publication
Oct 13, 2015
Published for Opposition
Oct 13, 2015
Registered
Dec 29, 2015

Trademark Image

EAGLE PHARMACEUTICALS

Basic Information

Serial Number
86296582
Registration Number
4876691
Filing Date
May 30, 2014
Registration Date
December 29, 2015
Published for Opposition
October 13, 2015
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Jun 9, 2022
Registration
Registered
Classes
035 042

Rights Holder

Eagle Pharmaceuticals, Inc.

03
Address
50 Tice Boulevard, Suite 315
Woodcliff Lake, NJ 07677

Ownership History

Eagle Pharmaceuticals, Inc.

Original Applicant
03
Woodcliff Lake, NJ

Eagle Pharmaceuticals, Inc.

Owner at Publication
03
Woodcliff Lake, NJ

Eagle Pharmaceuticals, Inc.

Original Registrant
03
Woodcliff Lake, NJ

Legal Representation

Attorney
John Mueller

USPTO Deadlines

Next Deadline
3642 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Extended from 2025-12-29)
Due Date
December 29, 2035
Grace Period Ends
June 29, 2036

Application History

36 events
Date Code Type Description Documents
Dec 29, 2025 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Dec 29, 2024 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jun 9, 2022 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jun 9, 2022 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jun 9, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Dec 20, 2021 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Dec 29, 2020 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Oct 9, 2017 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 9, 2017 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 29, 2015 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 13, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 13, 2015 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 23, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 10, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 3, 2015 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 6, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 6, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 15, 2015 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Apr 4, 2015 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Apr 4, 2015 GNFR O FINAL REFUSAL E-MAILED Loading...
Apr 4, 2015 CNFR R FINAL REFUSAL WRITTEN Loading...
Mar 12, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 12, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 6, 2015 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Mar 6, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 5, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 5, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 16, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 16, 2014 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 16, 2014 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 11, 2014 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 26, 2014 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Aug 19, 2014 ALIE A ASSIGNED TO LIE Loading...
Aug 14, 2014 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jun 12, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 3, 2014 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Commercialization of pharmaceutical products, namely, marketing in the field of pharmaceutical products
First Use Anywhere: Sep 6, 2011
First Use in Commerce: Sep 6, 2011
Class 042
Pharmaceutical product development for others
First Use Anywhere: Jan 2, 2007
First Use in Commerce: Feb 11, 2014

Classification

International Classes
035 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"